Tilray The international cannabis giant has announced plans to issue a ‘reverse stock split’, an increasingly common tool in
Tilray’s stock price has tumbled some 24% since the start of the week as its Q3 2025 financial figures failed
Stenocare Danish medical cannabis oil producer Stenocare has exited its cultivation facility in Denmark, just four years after it was
Argent BioPharma Argent Biopharma (previously MGC Pharmaceuticals) has completed a US$4.5 million capital raise to support its drug development
Akanda Corp NASDAQ-listed international medical cannabis operator Akanda Corp has seen its stock drop by double digits this week
Young US women are consuming more cannabis than men for the first time, according to recently published data from the US National Institute on Drug Abuse (NIDA).Â
Canadian medical cannabis clinic Santé Cannabis has started recruitment for a new study assessing the effectiveness of various cannabis treatment plans.Â
Tilray’s cannabis revenues fell sharply over its first quarter, but its overall revenues were up 13% thanks to a near doubling in revenues from its alcohol business.Â
Canadian cannabis sales have continued their mixed performance through June 2024, seeing another dip in total sales, but some states
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has now issued the first three new licences for domestic cannabis
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
